{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:39:07Z","timestamp":1770838747589,"version":"3.50.1"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T00:00:00Z","timestamp":1388016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0083719","type":"journal-article","created":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T21:38:31Z","timestamp":1388093911000},"page":"e83719","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Glycome of Normal and Malignant Plasma Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Thomas M.","family":"Moehler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Seckinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindaugas","family":"Andrulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e8r\u00f4me","family":"Moreaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hielscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Willhauck-Fleckenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette","family":"Merling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Jauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Schwartz-Albiez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,12,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"RA Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/gcc.20231","article-title":"Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics","volume":"44","author":"FW Cremer","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report","volume":"64","author":"R Fonseca","year":"2004","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2141.2006.06271.x","article-title":"Long-term outcome results of the first tandem autotransplant trial for multiple myeloma","volume":"135","author":"B Barlogie","year":"2006","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMct0805626","article-title":"Autologous hematopoietic stem-cell transplantation for multiple myeloma","volume":"360","author":"JL Harousseau","year":"2009","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2141.2009.07864.x","article-title":"TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3","volume":"147","year":"2009","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1182\/blood-2009-11-255620","article-title":"Superior results of Total Therapy 3 (2003-33) in gene expression profiling-defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance","volume":"115","author":"B Nair","year":"2010","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood-2008-10-184226","article-title":"Induction of angiogenesis by normal and malignant plasma cells","volume":"114","author":"D Hose","year":"2009","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/onc.2009.257","article-title":"Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis","volume":"28","author":"A Seckinger","year":"2009","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2407-10-198","article-title":"Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays","volume":"10","author":"K Mahtouk","year":"2010","journal-title":"BMC Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ceb.2003.08.002","article-title":"Glycan-dependent leukocyte adhesion and recruitment in inflammation","volume":"15","author":"JB Lowe","year":"2003","journal-title":"Curr Opin Cell Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.cbpa.2007.05.002","article-title":"Deciphering the glycocode: the complexity and analytical challenge of glycomics","volume":"11","author":"KT Pilobello","year":"2007","journal-title":"Curr Opin Chem Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1349-7006.2004.tb03219.x","article-title":"Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis","volume":"95","author":"R Kannagi","year":"2004","journal-title":"Cancer Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2141.2009.07633.x","article-title":"Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells","volume":"145","author":"C Bret","year":"2009","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1479-5876-9-72","article-title":"SULFs in human neoplasia: implication as progression and prognosis factors","volume":"9","author":"C Bret","year":"2011","journal-title":"J Transl Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1038\/sj.onc.1208536","article-title":"Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells","volume":"24","author":"K Mahtouk","year":"2005","journal-title":"Oncogene"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1038\/sj.onc.1209699","article-title":"Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma","volume":"25","author":"K Mahtouk","year":"2006","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V99.4.1405","article-title":"Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma","volume":"99","author":"PW Derksen","year":"2002","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0609.2009.01262.x","article-title":"APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop","volume":"83","author":"J Moreaux","year":"2009","journal-title":"Eur J Haematol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1182\/blood-2008-07-170464","article-title":"The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor","volume":"113","author":"AC Sprynski","year":"2009","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"13326","DOI":"10.1074\/jbc.M611259200","article-title":"Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis","volume":"282","author":"Y Yang","year":"2007","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1182\/blood-2006-08-043232","article-title":"Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma","volume":"109","author":"K Mahtouk","year":"2007","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1182\/blood-2009-02-204396","article-title":"Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma","volume":"115","author":"RM Reijmers","year":"2010","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","article-title":"A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1","volume":"109","author":"JD Shaughnessy Jr","year":"2007","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","article-title":"Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome","volume":"109","author":"H Avet-Loiseau","year":"2007","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2010.030296","article-title":"Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma","volume":"96","author":"D Hose","year":"2011","journal-title":"Haematologica"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"PR Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","article-title":"Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant","volume":"102","author":"J Blade","year":"1998","journal-title":"Br J Haematol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"BG Durie","year":"2006","journal-title":"Leukemia"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa053583","article-title":"Thalidomide and hematopoietic-cell transplantation for multiple myeloma","volume":"354","author":"B Barlogie","year":"2006","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2008-09-178350","article-title":"Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma","volume":"113","author":"D Hose","year":"2009","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/sj.leu.2401632","article-title":"Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors","volume":"14","author":"ZJ Gu","year":"2000","journal-title":"Leukemia"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1182\/blood.V91.12.4727","article-title":"A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma","volume":"91","author":"C Rebouissou","year":"1998","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/sj.leu.2400971","article-title":"Malignant plasma cell lines express a functional CD28 molecule","volume":"12","author":"XG Zhang","year":"1998","journal-title":"Leukemia"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1158\/1078-0432.CCR-11-1628","article-title":"Gene expression profiling in multiple myeloma\u2014reporting of entities, risk, and targets in clinical routine","volume":"17","author":"T Meissner","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10456-010-9162-4","article-title":"Transcriptional regulation of the vascular endothelial glycome by angiogenic and inflammatory signalling","volume":"13","author":"M Willhauck-Fleckenstein","year":"2010","journal-title":"Angiogenesis"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Warren P, Taylor D, Martini P, Jackson J, Bienkowska JR (2007) PANP-a new method of gene detection on oligonucleotide expression arrays. BIBE 2007 Proceedings of the 7th IEEE International conference on Bioinformatics and Bioengineering 108\u2013115.","DOI":"10.1109\/BIBE.2007.4375552"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10719-006-9000-5","article-title":"Differential surface expression and possible function of 9-O- and 7-O-acetylated GD3 (CD60 b and c) during activation and apoptosis of human tonsillar B and T lymphocytes","volume":"23","author":"M Erdmann","year":"2006","journal-title":"Glycoconj J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2011-09-379164","article-title":"Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p","volume":"119","author":"K Neben","year":"2012","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.leu.2403586","article-title":"Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma","volume":"19","author":"S Wuilleme","year":"2005","journal-title":"Leukemia"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3324\/haematol.2011.061051","article-title":"Loss of endothelial thrombomodulin predicts response to steroid therapy and survival in acute intestinal graft-versus-host disease","volume":"97","author":"M Andrulis","year":"2012","journal-title":"Haematologica"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1198\/016214504000000683","article-title":"A model-based background adjustment for oligonucleotide expression arrays","volume":"99","author":"Z Wu","year":"2004","journal-title":"Journal of the American Statistical Association"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/biostatistics\/kxh021","article-title":"The \u2018miss rate\u2019 for the analysis of gene expression data","volume":"6","author":"J Taylor","year":"2005","journal-title":"Biostatistics"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"Article3","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"GK Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.1665","article-title":"The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models","volume":"28","author":"L Shi","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/bioinformatics\/btg382","article-title":"A global test for groups of genes: testing association with a clinical outcome","volume":"20","author":"JJ Goeman","year":"2004","journal-title":"Bioinformatics"},{"key":"ref48","first-page":"42","article-title":"Decay-accelerating factor(CD55): A versatile acting molecule in human malignancies","volume":"1766","author":"J-H Nikesch","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0161-5890(99)00115-7","article-title":"Complement resistance of tumor cells: basal and induced mechanisms","volume":"36","author":"K Jurianz","year":"1999","journal-title":"Mol Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1021\/bi8006324","article-title":"The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins","volume":"47","author":"MG Paulick","year":"2008","journal-title":"Biochemistry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/gb-2008-9-5-224","article-title":"Glypicans","volume":"9","author":"J Filmus","year":"2008","journal-title":"Genome Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bone.2007.04.190","article-title":"Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity","volume":"41","author":"A Irie","year":"2007","journal-title":"Bone"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/febs.12180","article-title":"Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma","volume":"280","author":"R Reijmers","year":"2013","journal-title":"FEBS J"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0167-4889(95)00057-Y","article-title":"Modulated glycosylation of proteoglycans during differentiation of human B lymphocytes","volume":"1267","author":"S Engelmann","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4049\/jimmunol.158.3.1324","article-title":"Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1","volume":"158","author":"M Kirschfink","year":"1997","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0008-6215(97)00115-8","article-title":"Differential release of proteoglycans during human B lymphocyte maturation","volume":"302","author":"S Engelmann","year":"1997","journal-title":"Carbohydr Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0083719","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T08:58:46Z","timestamp":1688893126000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0083719"}},"subtitle":[],"editor":[{"given":"Srinivas","family":"Kaveri","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,26]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0083719","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,26]]}}}